Pregabalin Capsule
Product Images NDC 80425-0308

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Equation (Equation)

Equation (Equation)
This appears to be a calculation for estimating an individual's creatinine clearance (CLCT) using their age, weight, and serum creatinine level. However, the text is not complete and contains many errors in the form of non-English characters and unclear symbols. Further information is needed to provide a more detailed description.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
FDA Label Image

Fig 10 (Fig 10)

Fig 10 (Fig 10)
This appears to be a chart showing the percentage of subjects without LTR (unknown definition) for a medication called Progabain and a placebo, over a period of 120 to 180 days. Not much context is given, so it's unclear what the overall purpose of the study or chart is.*
FDA Label Image

Fig 11 (Fig 11)

Fig 11 (Fig 11)
FDA Label Image

Fig 12 (Fig 12)

Fig 12 (Fig 12)
The text describes a chart showing the percentage of subjects who experienced improvement over a period of 16 weeks, using both pregabalin and placebo. The chart displays percentage values between 100 and 280, separated by increments of 10.*
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
The text describes a chart or table indicating the percentage of patients who have improved along with a medication regimen of Pregabalin 160mg for three days. It also shows the percentage improvement in pain from baseline. However, there is some random text which is not decipherable.*
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
FDA Label Image

Fig 5 (Fig 5)

Fig 5 (Fig 5)
This appears to be a record of a medical study comparing the effectiveness of three different treatments for pain. The treatments were Fregabalin (100 mg, three times per day), Pregataiin (80 mg, three times per day), and a placebo. The table shows the percentage of patients who improved with each treatment, and the percentage improvement in pain from baseline.*
FDA Label Image

Fig 6 (Fig 6)

Fig 6 (Fig 6)
This appears to be a table or chart with some information about different studies, doses of medication (ranging from placebo to 600mg/day), and some indication that certain treatments were statistically significant compared to placebo. However, without more context or a clear understanding of what the table is trying to convey, it is difficult to provide a more specific or useful description.*
FDA Label Image

Fig 7 (Fig 7)

Fig 7 (Fig 7)
FDA Label Image

Fig 9 (Fig 9)

Fig 9 (Fig 9)
The text shows a graph measuring the percentage of patients improved using different doses of pregabalin (300mg and 450mg) compared to a placebo. The improvement is measured in pain reduction from a baseline measurement. The graph shows that the higher dose of pregabalin had a greater percentage of patient improvement than the lower dose and the placebo.*
FDA Label Image

Label 1 (Pregabalin 200mg 80425 0308 01)

Label 1 (Pregabalin 200mg 80425 0308 01)
This is a description of a medication named Pregabalin 200mg capsule, which comes in a quantity of 30. It is being compared to a drug called Lyrica. It also includes the NDC code, the source NDC code, and an expiration date of 8/31/2023. The rest of the text seems to be unrelated characters and is not available for understanding.*
FDA Label Image

Label 2 (Pregabalin 200mg 80425 0308 02)

Label 2 (Pregabalin 200mg 80425 0308 02)
This is a medication package for Pregabalin 200mg capsules that contains 60 capsules with a specific lot number and expiration date. The NDC and source NOC numbers are also provided for tracking purposes. The text "AIMHNHAARRED" followed by "<~" appears randomly and does not provide any relevant information.*
FDA Label Image

Label 3 (Pregabalin 200mg 80425 0308 03)

Label 3 (Pregabalin 200mg 80425 0308 03)
This is a medicine label for PREGABALIN 200MG CAPSULE. It contains information on the lot number, expiration date, and source NDC code. The recommended storage temperature is 20°C to 25°C. It is unclear what "Advanced % ST" and "S/ 0000001 38008" refer to.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.